Evidence map›Paper›PMID 28053678›Full record

ArticlePrzeglad gastroenterologiczny2016

Immunohistochemical assessment of mitochondrial superoxide dismutase (MnSOD) in colorectal premalignant and malignant lesions.

Adam Piecuch, Marlena Brzozowa-Zasada, Bartosz Dziewit, Oliwia Segiet, Józef Kurek, Grażyna Kowalczyk-Ziomek, Romuald Wojnicz, Krzysztof Helewski

Open access · goldAbstract read
In one paragraph

Article in Przeglad gastroenterologiczny, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Article
  3. A Prognostic Activity of Glutaredoxin 1 Protein (Grx1) in Colon Cancer.International journal of molecular sciences · 2024
    Article
  4. Article
  5. Catalase immunoexpression in colorectal lesions.Przeglad gastroenterologiczny · 2020
    Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Adam PiecuchChair and Department of Histology and Embryology, Faculty of Medicine and Dentistry in Zabrze, Medical University of Silesia in Katowice, Poland.
Marlena Brzozowa-ZasadaChair and Department of Histology and Embryology, Faculty of Medicine and Dentistry in Zabrze, Medical University of Silesia in Katowice, Poland.
Bartosz DziewitInstitute of Physics, University of Silesia, Katowice, Poland.
Oliwia SegietChair and Department of Histology and Embryology, Faculty of Medicine and Dentistry in Zabrze, Medical University of Silesia in Katowice, Poland.
Józef KurekMunicipal Hospital, Jaworzno, Poland.
Grażyna Kowalczyk-ZiomekChair and Department of Histology and Embryology, Faculty of Medicine and Dentistry in Zabrze, Medical University of Silesia in Katowice, Poland.
Romuald WojniczChair and Department of Histology and Embryology, Faculty of Medicine and Dentistry in Zabrze, Medical University of Silesia in Katowice, Poland.
Krzysztof HelewskiChair and Department of Histology and Embryology, Faculty of Medicine and Dentistry in Zabrze, Medical University of Silesia in Katowice, Poland.
Medical University of Silesia · PLUniversity of Silesia in Katowice · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIt is generally accepted that mitochondria are a primary source of intracellular reactive oxygen species (ROS). Under physiological circumstances they are permanently formed as by-products of aerobic metabolism in the mitochondria. To counter the harmful effect of ROS, cells possess an antioxidant defence system to detoxify ROS and avert them from accumulation at high concentrations. Mitochondria-located manganese superoxide dismutase (MnSOD, SOD2) successfully converts superoxide to the less reactive hydrogen peroxide (H

aimTo investigate the immunohistochemical expression status of MnSOD in colorectal premalignant and malignant lesions. MATERIAL AND

methodsThis study was performed on resected specimens obtained from 126 patients who had undergone surgical resection for primary sporadic colorectal cancer, and from 114 patients who had undergone colonoscopy at the Municipal Hospital in Jaworzno (Poland). Paraffin-embedded, 4-µm-thick tissue sections were stained for rabbit polyclonal anti SOD2 antibody obtained from GeneTex (clone TF9-10-H10 from America Diagnostica).

resultsResults of our study demonstrated that the development of colorectal cancer is connected with increased expression of MnSOD both in adenoma and adenocarcinoma stages. Samples of adenocarcinoma with G2 and G3 grade showed significantly higher levels of immunohistochemical expression of this antioxidant enzyme. Moreover, patients with the presence of lymphovascular invasion and higher degree of regional lymph node status have been also characterised by higher levels of MnSOD expression. The samples of adenoma have been characterised by higher levels of MnSOD expression in comparison to normal mucosa as well. Interestingly, there was no significant correlation between expression and histological type of adenoma.

conclusionsDevelopment of colorectal cancer is connected with increased expression of MnSOD both in adenoma and adenocarcinoma stages.

Indexed as

colorectal adenomacolorectal cancerimmunohistochemistrymanganese superoxide dismutaseoxidative stress

Identifiers

PMID28053678
PMCPMC5209461
OpenAlexW2329628158

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.